Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.12
0.09 (0.69%)
At close: Aug 15, 2025, 9:57 AM

Medifast Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
90.93M 94.44M 87.69M 104.18M
Short-Term Investments
71.42M 55.6M n/a 5.36M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
9.67M 14.65M 12.46M 6.47M
Receivables
n/a n/a n/a n/a
Inventory
42.42M 54.59M 118.86M 180.04M
Other Current Assets
n/a 10.67M 16.24M 16.33M
Total Current Assets
214.4M 224.03M 222.78M 306.87M
Property-Plant & Equipment
48.68M 67.11M 75.64M 80.59M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
69.81M 85.88M 93.43M 91.46M
Total Assets
284.21M 309.91M 316.21M 398.33M
Account Payables
23.05M 39.19M 53.12M 70.89M
Deferred Revenue
316K 574K 7.36M 8.05M
Short-Term Debt
n/a 5.88M 5.78M n/a
Other Current Liabilities
32.77M 35.12M 37.5M 45.92M
Total Current Liabilities
64.16M 92.3M 140.89M 169.83M
Long-Term Debt
n/a n/a 20.27M n/a
Other Long-Term Liabilities
n/a n/a -20.27M n/a
Total Long-Term Liabilities
9.94M 16.13M 20.27M 26.02M
Total Liabilities
74.1M 108.43M 161.17M 195.85M
Total Debt
16.13M 22.01M 26.05M 32.54M
Common Stock
n/a 11K 11K 12K
Retained Earnings
176.78M 174.65M 139.85M 190.33M
Comprehensive Income
180K 248K 24K 111K
Shareholders Equity
210.11M 201.48M 155.04M 202.47M
Total Investments
71.42M 55.6M n/a 5.36M